Protection of mice from fatal herpes simplex virus type 1 infection by adoptive transfer of cloned virus-specific and H-2-restricted cytotoxic T lymphocytes - PubMed (original) (raw)
Protection of mice from fatal herpes simplex virus type 1 infection by adoptive transfer of cloned virus-specific and H-2-restricted cytotoxic T lymphocytes
K K Sethi et al. J Gen Virol. 1983 Feb.
Abstract
A cloned culture of secondary anti-herpes simplex virus (anti-HSV) cytotoxic T lymphocytes (CTL) generated in vitro when adoptively transferred to intact or cyclophosphamide (CP) pretreated syngeneic mice protected the recipients from death following intraperitoneal infection with HSV-1. This in vivo protective effect conferred by anti-HSV CTL was virus-specific and H-2K/D-restricted. Twenty-four h after HSV-1 infection of BALB/c mice (intact or CP-pretreated) relatively high levels of serum interferon-gamma were observed in the recipients of syngeneic anti-HSV CTL and this event may explain, at least in part, the CTL-mediated protective effect.
Similar articles
- The role of T cells in anti-herpes simplex virus immunity. I. Induction of antigen-specific cytotoxic T lymphocytes.
Pfizenmaier K, Jung H, Starzinski-Powitz A, Röllinghoff M, Wagner H. Pfizenmaier K, et al. J Immunol. 1977 Sep;119(3):939-44. J Immunol. 1977. PMID: 70478 - Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes.
Jennings SR, Rice PL, Pan S, Knowles BB, Tevethia SS. Jennings SR, et al. J Immunol. 1984 Jan;132(1):475-81. J Immunol. 1984. PMID: 6197457 - T cell responses to herpes simplex viruses in humans.
Schmid DS, Mawle AC. Schmid DS, et al. Rev Infect Dis. 1991 Nov-Dec;13 Suppl 11:S946-9. doi: 10.1093/clind/13.supplement_11.s946. Rev Infect Dis. 1991. PMID: 1685796 Review. - Pathogenesis and immunobiology of herpes simplex virus in mouse and man.
Jayasuriya AK, Nash AA. Jayasuriya AK, et al. Cancer Invest. 1985;3(2):199-207. doi: 10.3109/07357908509017504. Cancer Invest. 1985. PMID: 3158381 Review. No abstract available.
Cited by
- Presence of CD80 and Absence of LAT in Modulating Cellular Infiltration and HSV-1 Latency.
Jaggi U, Ghiasi H. Jaggi U, et al. Viruses. 2024 Aug 29;16(9):1379. doi: 10.3390/v16091379. Viruses. 2024. PMID: 39339855 Free PMC article. - Role of TH17 Responses in Increasing Herpetic Keratitis in the Eyes of Mice Infected with HSV-1.
Hirose S, Jaggi U, Wang S, Tormanen K, Nagaoka Y, Katsumata M, Ghiasi H. Hirose S, et al. Invest Ophthalmol Vis Sci. 2020 Jun 3;61(6):20. doi: 10.1167/iovs.61.6.20. Invest Ophthalmol Vis Sci. 2020. PMID: 32516406 Free PMC article. - Herpes Simplex Virus 1 ICP22 Suppresses CD80 Expression by Murine Dendritic Cells.
Matundan H, Ghiasi H. Matundan H, et al. J Virol. 2019 Jan 17;93(3):e01803-18. doi: 10.1128/JVI.01803-18. Print 2019 Feb 1. J Virol. 2019. PMID: 30404803 Free PMC article. - Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSV.
Mazzacurati L, Marzulli M, Reinhart B, Miyagawa Y, Uchida H, Goins WF, Li A, Kaur B, Caligiuri M, Cripe T, Chiocca EA, Amankulor N, Cohen JB, Glorioso JC, Grandi P. Mazzacurati L, et al. Mol Ther. 2015 Jan;23(1):99-107. doi: 10.1038/mt.2014.177. Epub 2014 Sep 9. Mol Ther. 2015. PMID: 25200130 Free PMC article. - Role of CD8+ T cells and lymphoid dendritic cells in protection from ocular herpes simplex virus 1 challenge in immunized mice.
Matundan H, Mott KR, Ghiasi H. Matundan H, et al. J Virol. 2014 Jul;88(14):8016-27. doi: 10.1128/JVI.00913-14. Epub 2014 May 7. J Virol. 2014. PMID: 24807710 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous